Showing results (171-180 of 219) with videos related to
Sort By:
Pageof 22
The Oncologist|September 22, 2011
Breast medical oncologists' use of standard prognostic factors to predict a 21-gene recurrence scoreArif H Kamal, Charles L Loprinzi, Carol Reynolds, et al.International Journal of Radiation Oncology, Biology, Physics|July 20, 2010
Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guidelineBenjamin D Smith, Soren M Bentzen, Candace R Correa, et al.The New England Journal of Medicine|September 3, 2004
Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancerKevin S Hughes, Lauren A Schnaper, Donald Berry, et al.JAMA Network Open|October 9, 2020
Regional Lymph Node Involvement Among Patients With De Novo Metastatic Breast CancerAlmir Bitencourt, Carolina Rossi Saccarelli, Elizabeth A Morris, et al.Journal of the National Comprehensive Cancer Network : JNCCN|February 10, 2009
Predictors and temporal trends of adjuvant aromatase inhibitor use in breast cancerTiffany H Svahn, Joyce C Niland, Robert W Carlson, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 29, 2026
Developing the multidisciplinary and multispecialty workforce and the systems needed to sustain high-quality care from diagnosis through long-term survivorshipYoungjee Choi, Erin P Balogh, Smita Bhatia, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2017
Tumor BRCA1 Reversion Mutation Arising during Neoadjuvant Platinum-Based Chemotherapy in Triple-Negative Breast Cancer Is Associated with Therapy ResistanceAnosheh Afghahi, Kirsten M Timms, Shaveta Vinayak, et al.JCO Oncology Practice|August 5, 2024
Re-Envisioning Electronic Health Records to Optimize Patient-Centered Cancer Care, Quality, Surveillance, and ResearchAditi P Singh, Erin P Balogh, Robert W Carlson, et al.The Breast Journal|July 5, 2012
Adjuvant therapy in stage I carcinoma of the breast: the influence of multigene analyses and molecular phenotypingGordon F Schwartz, Harry Bartelink, Harold J Burstein, et al.Proceedings of the National Academy of Sciences of the United States of America|May 20, 2009
Impaired interferon signaling is a common immune defect in human cancerRebecca J Critchley-Thorne, Diana L Simons, Ning Yan, et al.Pageof 22